We wrapped up #Sobrice2024 in São Paulo, Brazil earlier this month and had an incredible time meeting with physicians! Thank you to SOBRICE - Sociedade Brasileira de Radiologia Intervencionista e Cirurgia Endovascular for hosting another incredible event, to our team for engaging with the community, and to those who stopped by to speak with our team. We're already looking forward to next year!
About us
Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. More than 100,000 doses have been supplied to treat patients with liver cancer at more than 1,300 medical centers in over 50 countries. Together the team at Sirtex is introducing innovative new therapies that promise to improve the lives of people around the world facing the challenges of cancer. Our ongoing success is based on our commitment to serving our medical customers, professionalism, a collaborative working culture, an entrepreneurial spirit, continuous improvement and innovation. We are dedicated to making Sirtex a great place to work and providing all our employees with a range of benefits, programs and services to ensure they have the opportunity to contribute to the success of our business and further their professional careers. We are an equal opportunity employer. For more information, visit www.sirtex.com and connect with us on Twitter and Facebook. SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd.
- Website
-
http://www.sirtex.com
External link for Sirtex Medical Limited
- Industry
- Medical Equipment Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Woburn, MA
- Type
- Privately Held
Locations
-
Primary
300 Unicorn Park Drive
Woburn, MA 01801, US
-
207 Pacific Hwy
Shop 6
St Leonards, New South Wales 2065, AU
-
Joseph-Schumpeter-Allee 33
Bonn, 53227, DE
-
50 Science Park Road #01-01
Science Park II
Singapore, 117406, SG
Employees at Sirtex Medical Limited
Updates
-
As #IOAwarenessWeek comes to a close, we want to reiterate how proud we are to partner with interventional oncologists to streamline physician processes and improve the patient experience. Thank you so much to those who have partnered with us in the past - we're always looking to build more relationships, so if you're interested in connecting, send us a DM or reach out to your Sirtex representative.
-
It's #IOAwarenessWeek and we're celebrating interventional oncologists across the globe! Our team is always grateful to collaborate with physicians so that together, we can make forward strides in patient care. Get involved this week by following Society of Interventional Oncology and visiting this website: https://lnkd.in/dcwWaurg
-
That's a wrap on #SIR24EDGE! Thank you Society of Interventional Radiology for hosting & to everyone who stopped to talk with our team about SIR-Spheres® #Y90 resin microspheres and our FLEXdose SELECT Delivery Program. For more info on our Y-90 offerings, visit our website: https://lnkd.in/emZsEHyK
-
It's Day 1 of #SIR24EDGE in Denver, CO with Society of Interventional Radiology! Our team is eager to chat with physicians and industry professionals about the future of interventional radiology and our #Y90 product portfolio. Check out the event schedule: https://lnkd.in/eBnPmDEZ
-
Physicians can stop arterial bleeding and hemorrhage with the LAVA® Liquid Embolic System! The 2mL vial comes with two 1mL delivery syringes and the 6mL vial offers six 1mL delivery syringes, enabling multi-zone embolization options from 1 pre-mixed vial. Learn more about LAVA here: https://lnkd.in/e9bvwd7T
-
See you next week in Colorado for #SIR24EDGE with Society of Interventional Radiology! From Thursday, October 17 - Saturday October 19, you can learn about SIR-Spheres® #Y90 resin microspheres and our FLEXdose SELECT Delivery Program. Check out the full event details here: https://lnkd.in/eBnPmDEZ
-
ICYMI: Our innovative SIROS™ Delivery System for SIR-Spheres® Y-90 resin microspheres is now available in the European Union! We're proud to enhance treatment options in this region for unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer (mCRC) in patients refractory to or intolerant of chemotherapy. Physicians in the EU can learn more here: https://www.sirtex.com/eu/
-
We're proud to partner with Colontown and Dr. Farshid Dayyani, MD, PhD to share easy-to-understand information around mCRC, treatment strategies for liver-dominant diseases, SIR-Spheres® and more! Thank you to Dr. Dayyani for sharing your expertise during this DocTalk webinar. If you missed the live session, you can still watch the recording here: https://lnkd.in/etk7TPmQ
-
Physicians across the U.S. are embracing our SIR-Spheres® FLEXdose SELECT Delivery Program! With up to 5 delivery options every day of the week, physicians can enhance the precision, effectiveness and convenience of #Y90 therapy. This innovative treatment program offers patients a customized plan, personalized dosing, optimal tumor coverage and minimal exposure to healthy liver tissue. See if this program is right for you or someone you know by visiting our website: https://lnkd.in/e5drVxK7